Shenzhuo formulation ameliorates diabetic nephropathy by regulating cytochrome P450-mediated arachidonic acid metabolism
SZF exerts anti-inflammatory and antioxidant effects by regulating CYP450-mediated AA metabolism, leading to improved renal function and improved pathological state in DN mice.
Authors
- Yuansong Wang (ORCID: https://orcid.org/0000-0002-4695-6011)
- Weibo Wen (ORCID: https://orcid.org/0000-0002-9303-7341)
- Hui Zhang (ORCID: https://orcid.org/0000-0002-4442-2788)
- Zhongyong Zhang (ORCID: https://orcid.org/0009-0006-1406-0292)
- Shuquan Lv (ORCID: https://orcid.org/0000-0002-7129-3934)
- Huantian Cui (ORCID: https://orcid.org/0000-0002-0820-5436)
- Lixin Wang
- Duo Wang (ORCID: https://orcid.org/0000-0002-0674-4487)
- Ning Wang (ORCID: https://orcid.org/0000-0003-1410-329X)
- Yuming Wang (ORCID: https://orcid.org/0000-0003-2310-1456)
- Yongjun Cao (ORCID: https://orcid.org/0000-0002-8135-8914)
Institutions
- Tianjin University of Traditional Chinese Medicine (CN)
- North China University of Science and Technology (CN)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2025-04-24
- DOI
- https://doi.org/10.4239/wjd.v16.i5.103511
- Citations
- 1
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 1.11